Innovative Product Solutions

Our opportunities for innovation span a range of product solution platforms that cross our consumer, pharmaceutical, and medical devices and diagnostics businesses:

Anti-infectives
Antifungal
Audiology
Cardiovascular
Central nervous system
Dental
Diagnostics
Dialysis
Gastrointestinals
Hematology
IV/vascular access
Imaging
Immune-mediated inflammatory disorders
Needles and sutures

Neurology
Nutritionals
Oncology
Oral care
Orthopaedics
Pain and inflammation
Patient monitoring
Respiratory
Skin care
Surgical instruments
Urology
Vision care
Women's health
Wound care

Innovations within each of these product platforms take shape through a number of avenues, including:

Aggressive investment in research and development

To ensure our continued growth, we make a vigorous commitment to research and development in all business segments. Our R&D network is strong and well-equipped, with substantial annual investments. Through world-class research facilities, highly productive small team settings, and sound scientific methods, we build a pipeline and patent estate that match the breadth of our product platforms.

Focus on new convergence in the marketplace

Our strong commitment to R&D, as well as our focus on new technologies, has positioned Johnson & Johnson as a market leader ready to capitalize on the rapidly evolving health care landscape. As the marketplace sees a new and steady convergence between technology, products, and services, we see ourselves as uniquely positioned to meet the challenges and opportunities that are emerging.

Extensive collaboration and strategic alliances

Our broad base in health care offers our companies a unique source of innovative product solutoins: Internal collaborations both within and across business segments.

Experts within specific product platforms extend their impact as they identify synergies and establish collaborative development relationships with colleagues throughout our Family of Companies. The ability to work across company boundaries enables true collaborative innovation, and sets the stage for important health care breakthroughs in the future.

Additionally, each year, Johnson & Johnson companies enter into hundreds of strategic alliances. These alliances combine the unique strengths of external partners, which, when combined with those of our businesses, build value for customers.

Selective licensing and acquisition

We proactively search for innovations from outside our organizations as well. Our conscientious approach to assessing licensing and acquisition opportunities has helped us expand this important source of growth.

Find more

Explore examples of our three principal sources of product innovation and other related topics through the Points of Interest links provided on this page.